Quasar did not receive FDA clearance for claims of collagen/elastin production as stated on the packaging and in the user manuals.
Source facts
Action
Quasar Bio-Tech notified customers on about 06/20/2018 via URGENT PRODUCT RECALL letter. Instructions included place any current, affected inventory on hold and arrange for return to Quasar Bio-Tech, Inc. Customers were also instructed to complete and return the reply form.
Questions or concerns should be directed to Quasar Bio-Tech, Inc., at 800-944-1523 or 941-306-5812.
Initiated
2018-06-29
Root cause
Under Investigation by firm
Terminated
2019-08-27
Distribution
Nationwide distribution to CA, FL, GA, HI, IL, LA, MD, NE, NY, OH, TX, VA, WA, WI.
Worldwide distribution to Australia, China, Netherlands, United Kingdom
Recall number
Z-2975-2018
Recall status
Terminated
CDRH record ID
165717
FDA record created
2018-09-05
Recall event number
80496
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.